欧洲智能药丸市场预测至 2028 年 - COVID-19 影响和按应用（胶囊内窥镜检查、药物输送和患者监测）、疾病适应症（胃肠道疾病、神经系统疾病、癌症、遗传性疾病和其他疾病适应症）进行的区域分析，以及最终用户（医院和诊所、研究所和家庭医疗保健）
No. of Pages: 126 | Report Code: BMIRE00025429 | Category: Life Sciences
No. of Pages: 126 | Report Code: BMIRE00025429 | Category: Life Sciences
战略合作对于智能药丸市场的整体增长至关重要，因为这些合作有助于提高参与者的影响力在市场上。参与者参与合并、收购、合资和合作。此外，智能药丸市场的投资水平正在快速增长。智能药丸在民众中的日益普及吸引了一些投资者。各种公司和投资公司正在大力投资合并、收购和初创企业。这些因素有助于促进智能药丸市场的增长。研究机构与研究机构之间的合作协议公司、许可协议和公司之间的合作伙伴关系以及智能药丸研发投资的增加是推动市场增长的其他一些因素。例如，2021 年 1 月，etectRx, Inc. 与 Pear Therapeutics, Inc. 签订合作协议，在中枢神经系统领域开发两种候选产品，整合依从性传感器和处方数字疗法 (PDT)。这是探索将数字药丸解决方案与 PDT 结合使用的首个此类合作伙伴关系。 2020年8月，大冢以1500万美元收购了智能药丸制造商Proteus Digital Health。
凭借新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动智能药丸市场的发展。预计欧洲智能药丸市场在预测期内将以良好的复合年增长率增长。
欧洲智能药丸市场细分
欧洲智能药丸市场根据应用、疾病适应症和最终用户进行细分。根据应用，市场分为胶囊内窥镜、药物输送和患者监护。胶囊内窥镜细分为小肠视频胶囊内窥镜、结肠胶囊内窥镜、可控胶囊内窥镜、可储存胶囊内窥镜和其他胶囊内窥镜。根据疾病适应症，市场分为胃肠道疾病、神经系统疾病、癌症、遗传性疾病和其他疾病适应症。根据最终用户，市场分为医院和诊所、研究机构和家庭医疗保健。按国家/地区划分，欧洲智能药丸市场分为英国、德国、法国、意大利、西班牙和欧洲其他地区。
欧洲智能药丸市场 – 提及的公司
美敦力；宾得医疗；奥林巴斯公司；身体帽；和大冢控股有限公司是欧洲智能药丸市场的领先公司之一。
Strategic insights for Europe Smart Pills involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 934.08 Million |
| Market Size by 2028 | US$ 2,054.19 Million |
| Global CAGR (2021 - 2028) | 11.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 应用
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Smart Pills refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
1.Medtronic
2.PENTAX Medical
3.Olympus Corporation
4.BodyCap
5.Otsuka Holdings Co., Ltd.
The Europe Smart Pills Market is valued at US$ 934.08 Million in 2021, it is projected to reach US$ 2,054.19 Million by 2028.
As per our report Europe Smart Pills Market, the market size is valued at US$ 934.08 Million in 2021, projecting it to reach US$ 2,054.19 Million by 2028. This translates to a CAGR of approximately 11.9% during the forecast period.
The Europe Smart Pills Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Smart Pills Market report:
The Europe Smart Pills Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Smart Pills Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Smart Pills Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Smart Pills Market
